Bessemer Group
EVH icon

Bessemer Group’s Evolent Health EVH Stock Holding History

Bessemer Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-68
Closed -$1K – 2547
2025
Q2 		$1K Hold
68
– – ﹤0.01% 2296
2025
Q1 		$1K Buy
+68
New +$687 ﹤0.01% 2335
2024
Q4 		– Sell
-105
Closed -$3K – 2517
2024
Q3 		$3K Buy
+105
New +$2.71K ﹤0.01% 2083
2024
Q2 		– Sell
-3,313
Closed -$109K – 2063
2024
Q1 		$109K Hold
3,313
– – ﹤0.01% 1161
2023
Q4 		$109K Hold
3,313
– – ﹤0.01% 1191
2023
Q3 		$90K Hold
3,313
– – ﹤0.01% 1229
2023
Q2 		$100K Hold
3,313
– – ﹤0.01% 1224
2023
Q1 		$108K Sell
3,313
-10,929
-77% -$346K ﹤0.01% 1054
2022
Q4 		$400K Buy
+14,242
New +$408K ﹤0.01% 771
2021
Q1 		– Sell
-710
Closed -$11K – 1539
2020
Q4 		$11K Buy
+710
New +$9.38K ﹤0.01% 1278

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bessemer Group's EVH Position: Q3 2025 in Review

Bessemer Group sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 68 shares — an estimated $1K sold.

Bessemer Group first reported a position in EVH in Q4 2020 and held it in 10 quarters. The position peaked at $400K in Q4 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Bessemer Group reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Bessemer Group sold 68 Evolent Health shares in Q3 2025, an estimated $1K.
  • Bessemer Group first reported a position in Evolent Health in Q4 2020 and held it in 10 quarters.
  • Bessemer Group's Evolent Health position peaked at $400K in Q4 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.